Kinetic Transition in Amyloid Assembly as a Screening Assay for Oligomer-Selective Dyes
Open Access
- 27 September 2019
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 9 (10) , 539
Abstract
Assembly of amyloid fibrils and small globular oligomers is associated with a significant number of human disorders that include Alzheimer’s disease, senile systemic amyloidosis, and type II diabetes. Recent findings implicate small amyloid oligomers as the dominant aggregate species mediating the toxic effects in these disorders. However, validation of this hypothesis has been hampered by the dearth of experimental techniques to detect, quantify, and discriminate oligomeric intermediates from late-stage fibrils, in vitro and in vivo. We have shown that the onset of significant oligomer formation is associated with a transition in thioflavin T kinetics from sigmoidal to biphasic kinetics. Here we showed that this transition can be exploited for screening fluorophores for preferential responses to oligomer over fibril formation. This assay identified crystal violet as a strongly selective oligomer-indicator dye for lysozyme. Simultaneous recordings of amyloid kinetics with thioflavin T and crystal violet enabled us to separate the combined signals into their underlying oligomeric and fibrillar components. We provided further evidence that this screening assay could be extended to amyloid-β peptides under physiological conditions. Identification of oligomer-selective dyes not only holds the promise of biomedical applications but provides new approaches for unraveling the mechanisms underlying oligomer versus fibril formation in amyloid assembly.Keywords
Funding Information
- National Institute of General Medical Sciences (2R15GM097723-02)
This publication has 58 references indexed in Scilit:
- A long‐lived Aβ oligomer resistant to fibrillizationBiopolymers, 2018
- Effect of acidic and basic pH on Thioflavin T absorbance and fluorescenceEuropean Biophysics Journal, 2015
- In Situ Monitoring Alzheimer's Disease β‐Amyloid Aggregation and Screening of Aβ Inhibitors Using a Perylene ProbeSmall, 2012
- Protein aggregation: Mechanisms and functional consequencesThe International Journal of Biochemistry & Cell Biology, 2012
- Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils—current statusJournal of Chemical Biology, 2009
- Amyloid Protofibrils of Lysozyme Nucleate and Grow Via Oligomer FusionBiophysical Journal, 2009
- Folding versus aggregation: Polypeptide conformations on competing pathwaysArchives of Biochemistry and Biophysics, 2008
- Pre-assembled clusters distort crystal nucleation kinetics in supersaturated lysozyme solutionsBiophysical Chemistry, 2007
- Dibenzothiazoles as novel amyloid-imaging agentsBioorganic & Medicinal Chemistry, 2007
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004